IDG’s Bio-IT World and Cambridge Healthtech Institute Announce Joint Marketing Agreement

FRAMINGHAM, MA and NEWTON UPPER FALLS, MA – FEBRUARY 14, 2003 – IDG's Bio-IT World, the premier publication covering technology for the life sciences, today announced a marketing partnership with Cambridge Healthtech Institute (CHI). Under the terms of the agreement, Bio-IT World will serve as a CHI lead publication, and will market CHI conferences to its audience of more than 40,000 executives, as well as to its marketing clients at leading IT, informatics, life science equipment and business services companies. Bio-IT World's audience is comprised of information technology managers, senior scientists, and research and development managers in biotechnology, pharmaceutical, academic, healthcare and government research facilities.

 

This agreement allows Bio-IT World to extend its integrated marketing offerings for technology suppliers to include advanced bio-science conferences – in addition to Bio-IT World's currently available print and online offerings – and provides multiple opportunities for face-to-face interaction with scientists and technologists at key life sciences organizations.

"CHI has established itself as the thought-leader in the scientific conference arena through its delivery of specialized content and outstanding customer service over the past decade, to both attendees and conference sponsors and exhibitors," said Alan Bergstein, senior vice president and publisher, Bio-IT World, Inc. "We are delighted to make these quality events accessible to our targeted community of readers and technology clients."

Bio-IT World's inter-disciplinary audience will benefit from this partnership by gaining exposure to the highly focused content and intellectual leadership that CHI brings to bear in the scientific community. Information technology vendors will gain access to senior-level scientists in targeted, face-to face environments; and life science equipment suppliers will reach the new breed of technology professional who has an increasingly critical role in the scientific R&D process.

"Genomics and drug discovery have become information-driven fields. This has been reflected in a growing range of CHI conferences and strategic reports for which informatics plays a key role. One of CHI's primary aims is to bring those with expertise as end-users of technology together with those who have expertise in the technologies themselves," said Phillips Kuhl, president, Cambridge Healthtech Institute. "Bio-IT World is the ideal publication to partner with to enhance our efforts to reach this important audience. I look forward to exploring all the ways in which our organizations can work together to provide this segment with improved access to information resources and events regarding successes driven by bio-IT."

About Cambridge Healthtech Institute (CHI)

Established in 1992 as a conference organizer, Cambridge Healthtech Institute (CHI) has evolved into the premier information resource for life science professionals. Our goal is to produce the highest quality products and services that provide organizations and individuals with timely updates on new research, while offering insight into what the future of the industry may hold. Through the organization of scientific conferences, publication of market reports, and compilation of industry deals, CHI offers a one-stop source for learning about the latest technological and business developments in such areas as genomics, drug discovery and development, informatics and blood products safety. Leading CHI conferences include: Molecular Medicine Marketplace; Structure Based Drug Design; Intelligent Drug Discovery & Development (ID3); Beyond Genome; Microarray Data Analysis USA; and Data Visualization. Visit http://www.healthtech.com for more information.

About Bio-IT World, Inc.

A business unit of IDG, Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT professionals. Coverage focuses on the application of technology products and services to enable the life sciences R&D value chain in pharmaceutical, biotechnology, healthcare, government and academic research organizations, spanning basic research, drug discovery and development, clinical trials, and regulatory compliance. The company's premier publication, Bio-IT World, and accompanying website, www.bio-itworld.com, deliver the latest news, analysis and information on the technology infrastructure and applications driving innovation in the bio-IT community. Established in September 2001, Bio-IT World, Inc. is headquartered in Framingham, Mass.

About IDG

Bio-IT World is a business unit of IDG, the world's leading technology media, research and event company. IDG publishes more than 300 magazines and newspapers and offers online users the largest network of technology-specific sites around the world through IDG.net (www.idg.net), which comprises more than 330 targeted Web sites in 80 countries. IDG is also a leading producer of 168 computer-related events worldwide, and IDG's research company, IDC, provides global market intelligence and advice through 51 offices in 43 countries. Company information is available at www.idg.com.

 

# # #